1 |
|
Insights into liaison between antiepileptic drugs and bone |
Drug discovery today |
14 |
7-8 |
428-435 |
2009 |
Elsevier |
2 |
|
3-arylidene-5-(4-isobutylphenyl)-2 (3H)-furanones: a new series of anti-inflammatory and analgesic compounds having antimicrobial activity |
Journal of Enzyme Inhibition and Medicinal Chemistry |
25 |
3 |
323-330 |
2010 |
Taylor & Francis |
3 |
|
Microwave assisted one pot synthesis of some pyrazole derivatives as a safer anti-inflammatory and analgesic agents |
Acta Pol. Pharm |
70 |
3 |
435-441 |
2013 |
|
4 |
|
Search for New Pharmacophore as Antimalarial agent: Synthesis and antimalarial activity of some 2 (3H)-Furanones bearing quinoline moiety |
Acta. Pol. Pharm |
68 |
|
231-236 |
2011 |
|
5 |
|
BISPHOSPHONATES FOR ALLEVIATION OF PHENYTOIN-INDUCED BONE DISEASE IN MICE |
EPILEPSIA |
52 |
|
57-58 |
2011 |
WILEY-BLACKWELL COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA |
6 |
|
Bisphosphonates in phenytoin-induced bone disorder |
Bone |
48 |
3 |
597-606 |
2011 |
Elsevier |
7 |
|
EFFECTS OF BISPHOSPHONATE ON CALCIUM HOMEOSTASIS IN THE MANAGEMENT OF ANTIEPILEPTIC DRUG-INDUCED BONE LOSS IN MICE |
EUROPEAN JOURNAL OF NEUROLOGY |
18 |
|
173-173 |
2011 |
WILEY-BLACKWELL COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA |
8 |
|
Homocysteine in neurological disease: a marker or a cause? |
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) |
10 |
3 |
361-369 |
2011 |
Bentham Science Publishers |
9 |
|
Synthesis of some new 2-(substituted-phenyl)-5-(N, N-diphenylaminomethyl)-1, 3, 4-oxadiazoles: a safer anti-inflammatory and analgesic agents |
Acta Pol. Pharm |
68 |
3 |
381-386 |
2011 |
|
10 |
|
Synthesis of 6-aminomethyl derivatives of benzopyran-4-one with dual biological properties: anti-inflammatory-analgesic and antimicrobial |
European journal of medicinal chemistry |
44 |
12 |
4896-4903 |
2009 |
Elsevier Masson |
11 |
|
Role of NLRP3 inflammasome and its inhibitors as emerging therapeutic drug candidate for Alzheimerâs disease: a review of mechanism of activation, regulation, and inhibition |
Inflammation |
46 |
1 |
56-87 |
2023 |
Springer US New York |
12 |
|
A Quinquennial Review of Potent LSD1 Inhibitors explored for the treatment of different Cancers, with special focus on SAR studies |
Current Medicinal Chemistry |
31 |
2 |
152-207 |
2024 |
Bentham Science Publishers direct |
13 |
|
Synthesis, in-Silico studies and biological evaluation of Pyrimidine based Thiazolidinedione derivatives as potential Anti-diabetic agent |
Bioorganic Chemistry |
|
|
106449 |
2023 |
Academic Press |
14 |
|
quinoline incorporated 2(3H)-furanones as anti-inflammatory and analgesic agents |
Indian J Heterocyclic Chem |
20 |
2 |
185-66 |
2010 |
|
15 |
|
Effect of Rubia cordifolia alone or as an adjuvant with atorvastatin in experimental hyperlipidemia and atherosclerosis. |
|
|
|
|
2015 |
|
16 |
|
Synthesis and pharmacological evaluation of 2 (3H)-furanones and 2 (3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation |
European journal of medicinal chemistry |
44 |
6 |
2636-2642 |
2009 |
Elsevier |
17 |
|
Evaluation of tumor necrosis factor-α (TNF-α) levels in plasma and their correlation with periodontal status in obese and non-obese subjects |
Journal of Indian Society of Periodontology |
14 |
4 |
217-221 |
2010 |
Medknow |
18 |
|
A review on medicinal plants having antioxidant potential |
Indian Journal of Research in Pharmacy and Biotechnology |
1 |
3 |
404 |
2013 |
Indian Journal of Research in Pharmacy and Biotechnology |
19 |
|
ANTIEPILEPTIC DRUG-INDUCED OSTEOPOROSIS IN MICE: A MODEL TO STUDY MECHANISMS AND MANAGEMENT OF BONE LOSS IN EPILEPTICS |
OSTEOPOROSIS INTERNATIONAL |
23 |
|
S371-S372 |
2012 |
SPRINGER LONDON LTD 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND |
20 |
|
Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles |
European Polymer Journal |
|
|
113427 |
2024 |
Elsevier |
21 |
|
Folate-conjugated carbon nanotubes as a promising therapeutic approach for targeted cancer therapy |
Journal of Drug Targeting |
|
|
1-16 |
2024 |
Taylor & Francis |
22 |
|
Parkinsonâs Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen |
CNS & Neurological Disorders-Drug Targets |
|
|
|
2024 |
Bentham Science Publishers |